Recall Enforment Report D-1309-2020

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Hikma Pharmaceuticals USA Inc., originally initiated on 06-11-2020 for the product Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01 The product was recalled due to defective container: customer complaints received of a crimp defect while removing the flip-cap during use.. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-1309-202006-11-202006-24-2020Class II17,998 vialsIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.Terminated
D-1308-202006-11-202006-24-2020Class II82,426 vialsIrinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0143-9583Irinotecan Hydrochloride Irinotecan HydrochlorideInjectionIntravenousHikma Pharmaceuticals Usa Inc.Human Prescription Drug
0143-9701Irinotecan Hydrochloride Irinotecan HydrochlorideInjectionIntravenousHikma Pharmaceuticals Usa Inc.Human Prescription Drug
0143-9702Irinotecan Hydrochloride Irinotecan HydrochlorideInjectionIntravenousHikma Pharmaceuticals Usa Inc.Human Prescription Drug